COYA Coya Therapeutics, Inc.
Nasdaq · SEC CIK 1835022 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 54 since 2023-01-04, latest 2026-04-09 18:49
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| No open-market trades in the last year. | |||
Transactions 14
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-19 | 2025-08-18 | COYA | GOLDSTEIN DOV A MD | Dir | M - OptEx | $1.09 | +17.6K | 27.6K | +176% | +$19.1K |
| 2024-11-14 | 2024-11-14 | COYA | SNYDER DAVID S | CFO | P - Purchase | $7.19 | +1,800 | 8,800 | +26% | +$12.9K | |
| 2024-11-13 | 2024-11-13 | COYA | Swaminathan Arun | CEO, Dir | P - Purchase | $7.36 | +5,000 | 10.0K | +100% | +$36.8K | |
| 2024-11-12 | 2024-11-11 | COYA | Grossman Fred | Chief Medical Off | P - Purchase | $7.37 | +2,710 | 2,710 | New | +$20.0K | |
| 2024-11-12 | 2024-11-11 | COYA | Swaminathan Arun | CEO, Dir | P - Purchase | $7.34 | +5,000 | 5,000 | New | +$36.7K | |
| I | 2024-03-05 | 2023-08-22 | COYA | Lee Ann | Dir | P - Purchase | $3.62 | +1,000 | 17.5K | +6% | +$3,620 |
| D | 2023-01-04 | 2023-01-03 | COYA | Hepner Adrian | Chief Medical Off | P - Purchase | — | +10.0K | 10.0K | New | — |
| D | 2023-01-04 | 2023-01-03 | COYA | Garren Hideki | Dir | P - Purchase | — | +2,000 | 2,000 | New | — |
| D | 2023-01-04 | 2023-01-03 | COYA | Villalobos Anabella | Dir | P - Purchase | — | +10.0K | 10.0K | New | — |
| D | 2023-01-04 | 2023-01-03 | COYA | SNYDER DAVID S | CFO | P - Purchase | — | +7,000 | 7,000 | New | — |
| D | 2023-01-04 | 2023-01-03 | COYA | GOLDSTEIN DOV A MD | Dir | P - Purchase | — | +10.0K | 10.0K | New | — |
| D | 2023-01-04 | 2023-01-03 | COYA | Berman Howard | CEO, Dir, 10% | P - Purchase | — | +10.0K | 10.0K | New | — |
| D | 2023-01-04 | 2023-01-03 | COYA | Lee Ann | Dir | P - Purchase | — | +10.0K | 10.0K | New | — |
| D | 2023-01-04 | 2023-01-03 | COYA | Lee Ann | Dir | C - Cnv Deriv | $4.00 | +6,479 | 16.5K | +65% | +$25.9K |
Purchase Sale Sale after option exercise All abbreviations